Alumis, Inc. (ALMS)
5.60
-0.53
(-8.65%)
USD |
NASDAQ |
Nov 13, 16:00
5.55
-0.05
(-0.89%)
After-Hours: 19:59
Alumis EPS Diluted (Quarterly) : -0.7338 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.7338 |
| June 30, 2026 | -1.114 |
| March 31, 2026 | -0.7441 |
| December 31, 2025 | -0.8875 |
| September 30, 2025 | -1.064 |
| June 30, 2025 | 0.7741 |
| March 31, 2025 | -1.823 |
| December 31, 2024 | -1.742 |
| Date | Value |
|---|---|
| September 30, 2024 | -1.712 |
| June 30, 2024 | -1.039 |
| March 31, 2024 | -0.9615 |
| December 31, 2023 | -0.758 |
| September 30, 2023 | -0.8367 |
| June 30, 2023 | -0.70 |
| March 31, 2023 | -0.6949 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 0.0858 |
| BioAge Labs, Inc. | -0.7298 |
| ANI Pharmaceuticals, Inc. | 1.510 |
| Corcept Therapeutics, Inc. | 1.010 |
| Veru, Inc. | -0.3032 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -94.88M |
| Revenue (Quarterly) | 1.907M |
| Total Expenses (Quarterly) | 96.79M |
| Enterprise Value | 330.18M |
| Gross Profit Margin (Quarterly) | 53.70% |
| Profit Margin (Quarterly) | -4.98K% |
| Earnings Yield | -62.13% |
| Normalized Earnings Yield | -56.62 |